• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CSL Ltd

CMXHY:US

Ticker Delisted

Snapshot for CSL Ltd (CMXHY)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: 29.2300 - 33.1900 1-Yr Rtn: -

Stock Chart for CMXHY

No chart data available.
  • CMXHY:US 32.9300
  • 1M
  • 1Y
0.0000
Interactive CMXHY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CMXHY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 951.67
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.65%
Cash Dividend (USD) 0.2468
Dividend Ex-Date 03/07/2014
5 Year Dividend Growth 38.54%
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CMXHY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CMXHY

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

John ShineChairmanHan Willem KottermanVice Chairman
Paul PerreaultCEO/Managing DirectorGordon NaylorChief Financial Officer
More Company Profile & Key Executives for CMXHY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil